How Often Do You Need Allergy Shots? Build-Up vs Maintenance Schedules

During the build-up phase (the first 3-6 months), you visit the allergy clinic 1-2 times per week for conventional protocols, or 1-2 times per week with multiple injections per visit for cluster protocols. This is the highest-frequency period — approximately 52 total visits in the build-up year for conventional weekly scheduling. Once you reach your maintenance dose, visit frequency drops dramatically to once every 2-4 weeks — typically once per month for most patients. During maintenance, you attend approximately 12-17 visits per year. Each visit at any phase includes the injection itself (under 30 seconds) plus the mandatory 30-minute post-injection observation period, making each visit roughly 45-60 minutes including check-in and checkout. The total course spans 3-5 years from first injection to last.

The consequence of extended gaps between allergy shots depends on which phase of treatment you are in. During build-up: a gap of more than 7 days typically requires dose reduction to the previously tolerated level before re-escalation begins. Gaps of 2-4 weeks during build-up may require restarting from a significantly lower dose. Longer gaps may require restarting build-up from the beginning. During maintenance: gaps of 2-4 weeks are generally tolerable without dose adjustment. Gaps of 4-8 weeks usually require at least a modest dose reduction at the next visit to ensure safety. Gaps beyond 8-12 weeks often require more significant dose reduction, and very long gaps may require restarting the maintenance dose escalation. AAAAI dose adjustment guidelines provide the framework, but your allergist individualizes the protocol based on your specific reaction history and the exact length of the gap.

Some patients successfully maintain immunotherapy efficacy at 5-6 week maintenance intervals rather than the standard 3-4 weeks, but this should be determined by your allergist based on clinical evidence of sustained benefit — not self-directed schedule extension. Factors that support longer intervals: excellent symptom control during the extended interval, no loss of tolerance indicators, and stable specific IgE levels. Factors that suggest tighter intervals are needed: symptoms returning toward the end of each dosing cycle, or skin test reactivity that has not adequately suppressed. If you want to try extending from monthly to every 5-6 weeks, discuss this explicitly with your allergist and monitor symptoms carefully. The maintenance interval is not fixed in stone — it is an individualized parameter that the best allergists optimize per patient. Do not extend the interval independently without allergist knowledge.

No — the weekly frequency applies only to the build-up phase, which lasts 3-6 months. After build-up, maintenance drops to once per month (every 2-4 weeks). After the full 3-5 year course is completed, injections stop entirely. So the weekly commitment is a finite, front-loaded phase, not an indefinite requirement. Many patients find the build-up phase manageable when they understand it has a clear endpoint. The total visit count for a complete conventional course is approximately 90-140 injections spread over 3-5 years — the heaviest cluster in the first year (build-up) and gradually decreasing density as maintenance extends. After completing the full course, post-treatment monitoring involves clinical follow-up visits, not injections.

A cluster immunotherapy protocol is an accelerated build-up approach where 2-3 injections are administered per clinic visit on non-consecutive days, rather than one injection per weekly visit. This compresses the build-up timeline from the conventional 16-24 weeks down to approximately 4-8 weeks, while maintaining the same safety standard of 30-minute observation after each individual injection. During a cluster visit, each injection is given sequentially with 20-30 minutes between doses in the same visit. Pre-medication with antihistamines or corticosteroids before cluster visits is sometimes used to reduce the slightly elevated reaction risk of the accelerated protocol. Cluster protocols are particularly useful for patients who missed the optimal pre-seasonal start window, patients with highly demanding work schedules who cannot sustain weekly visits for 5 months, or patients who want to reach the less-demanding maintenance phase as quickly as possible. Your allergist must determine whether you are a suitable candidate for cluster build-up.

Most standard allergy shot visits involve one or two injections per visit. One injection per visit is the norm for conventional single-arm protocols. Two injections per visit (one in each arm simultaneously) are used when a patient's allergen extract requires bilateral administration — typically when the total maintenance volume exceeds what can safely be given in one arm, or when the protocol uses separate vials for different allergen groups (e.g., one vial for pollens and a separate vial for dust mite). During cluster build-up protocols, 2-3 sequential injections are given within the same visit, with 20-30 minute rest periods between each. Rush protocols involve multiple injections in rapid succession over 1-3 intensive days. The number of injections per visit is determined by your allergist based on your specific extract formulation, dose, and protocol. Regardless of how many injections per visit, the 30-minute observation period always begins after the last injection.